Finance

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

November 2, 2023

[#item_full_content]BOSTON & LONDON–(BUSINESS WIRE)–eXciteOSA therapy demonstrates high adherence, improvement in obstructive sleep apnea severity, and improvement in daytime sleepiness.